Key result
Treadmill exercise during doxorubicin treatment prevented cardiac dysfunction, reduced cardiac fibrosis, and restored cardiac function compared to the DOX-treated group.
Why the study?
Doxorubicin-induced cardiomyopathy can lead to heart failure, but treatments to mitigate this cardiac damage are still required.
Does treadmill exercise prevent cardiac dysfunction in a preclinical model of doxorubicin-induced cardiotoxicity?
Does treadmill exercise prevent cardiac dysfunction in a preclinical model of doxorubicin-induced cardiotoxicity?
Treadmill exercise during doxorubicin treatment mitigates cardiotoxicity by reducing inflammation and fibrosis, preserving cardiac function.
Answers are grounded in this paper and cite their sources.
Exercise may mitigate doxorubicin cardiotoxicity; hypothesis-generating and requires clinical trials before adoption.
Doxorubicin (DOX) is known as an effective drug in the fight against various cancers. However, one of the greatest impediments is DOX-induced cardiomyopathy, which may potentially lead to heart failure. Accumulating evidence has shed light on the pathological mechanism of DOX-induced cardiotoxicity, but treatments to mitigate the cardiac damage are still required. In an attempt to address this issue, we evaluated whether exercise provides cardioprotective effects on the DOX-induced cardiotoxicity. We showed that treadmill exercise (3 times/week; 1-week of exercise acclimatization and 4-weeks of endurance exercise) during the DOX treatment successfully prevented the cardiac dysfunction. The DOX-stimulated expression of IκBα, NF-κB, COX-2, and IL-8 were all downregulated by exercise as well as the fibrosis factors (TGF-β1, phosphorylated ERK, Sp1, and CTGF). Moreover, we showed that treadmill exercise diminished the expression of several cardiac remodeling-associated factors, such as FGF2, uPA, MMP2, and MMP9. These results were in line with the finding that exercise intervention reduced cardiac fibrosis and restored cardiac function, with higher values of ejection fraction and fractional shortening compared to the DOX-treated group. Two commonly used indicators of cardiac injury, lactate dehydrogenase, and creatine kinase-MB, were also decreased in the exercise group. Collectively, our results suggested that it may be beneficial to prescribe treadmill exercise as an adjunct therapy to limit cardiac damage caused by DOX.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2020) studied Doxorubicin-induced cardiotoxicity. Treadmill exercise vs. DOX-treated group was evaluated on Cardiac dysfunction and fibrosis. Treadmill exercise during doxorubicin treatment prevented cardiac dysfunction, reduced cardiac fibrosis, and restored cardiac function compared to the DOX-treated group.
Synapse has enriched 10 related papers. Consider them for comparative context: